International Journal of Angiology
Scope & Guideline
Illuminating the path to improved heart health worldwide.
Introduction
Aims and Scopes
- Vascular Disease Management:
The journal emphasizes research on the management and treatment strategies for vascular diseases, including both surgical and non-surgical approaches. - Cardiovascular Research:
A significant portion of the published papers focuses on cardiovascular health, addressing issues such as myocardial infarction, heart failure, and coronary artery disease. - Innovative Techniques and Technologies:
The journal highlights advancements in medical technologies and techniques used in the diagnosis and treatment of vascular conditions, including endovascular procedures and minimally invasive techniques. - Biomarkers and Pathophysiology:
Research on biomarkers and their role in the pathophysiology of vascular diseases, including inflammatory markers and genetic predispositions, is a consistent theme. - Epidemiology and Risk Factors:
The journal also addresses the epidemiological aspects of vascular diseases, exploring risk factors, prevalence, and outcomes in diverse populations. - Patient-Centered Care:
There is a focus on studies that assess patient outcomes, quality of life, and the effectiveness of various treatment modalities from a patient-centered perspective.
Trending and Emerging
- Pulmonary Embolism Management:
Recent publications reflect an increased emphasis on the management of pulmonary embolism, including prevention strategies and innovative treatment approaches, highlighting its clinical significance. - Endovascular Techniques:
There is a notable trend towards research on endovascular techniques, reflecting the growing importance of minimally invasive procedures in the treatment of vascular diseases. - Impact of COVID-19 on Vascular Health:
The journal has seen a rise in studies exploring the implications of COVID-19 on vascular health, including thromboembolic events, which have become a pressing concern in contemporary medicine. - Patient Outcomes and Quality of Life:
Emerging research increasingly prioritizes patient-centered outcomes, focusing on quality of life and long-term results of vascular interventions, indicating a shift towards holistic care. - Biomarkers in Vascular Disease:
Studies investigating the role of various biomarkers in the pathophysiology and management of vascular diseases are on the rise, reflecting a trend towards personalized medicine.
Declining or Waning
- Historical Perspectives:
Papers focusing on historical reviews or perspectives of vascular diseases are becoming less frequent, indicating a shift towards more contemporary and practical applications of research. - Basic Science Studies:
Research that is primarily theoretical or basic science-oriented, lacking direct clinical applications, seems to be less favored in recent issues. - Single Case Reports:
The frequency of case reports, particularly those without broader implications or insights, is declining in favor of larger studies with more significant clinical relevance. - Traditional Surgical Techniques:
There appears to be a diminishing focus on traditional surgical techniques that have been overshadowed by newer, less invasive methods and technologies. - General Reviews on Common Conditions:
General review articles on well-established conditions, such as hypertension and diabetes, are less common as the journal gravitates towards more specialized and innovative research.
Similar Journals
Journal of Cardiovascular Development and Disease
Innovating research for the future of cardiovascular health.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
Archives of Cardiovascular Diseases
Connecting clinicians and researchers for a healthier heart.The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Advancing cardiovascular knowledge for a healthier tomorrow.Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.
ACTA CARDIOLOGICA
Pioneering insights in cardiology and cardiovascular medicine.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Heart International
Advancing cardiovascular knowledge for a healthier tomorrow.Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.
REVISTA ESPANOLA DE CARDIOLOGIA
Connecting Clinicians and Researchers in CardiologyREVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.
Vasa-European Journal of Vascular Medicine
Connecting Researchers and Clinicians in Vascular ExcellenceVasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.
Vascular Health and Risk Management
Exploring the intersections of health, risk, and innovation.Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.
Indian Heart Journal
Advancing Cardiac Knowledge for a Healthier TomorrowIndian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.
Korean Circulation Journal
Pioneering Insights in Cardiology and Cardiovascular Medicine.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.